<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-218" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Heart Transplantation Allograft Vasculopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shetty</surname>
            <given-names>Mrin</given-names>
          </name>
          <aff>University of Chicago (NorthShore)</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chowdhury</surname>
            <given-names>Yuvraj S.</given-names>
          </name>
          <aff>State University of New York - Downstate</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mrin Shetty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yuvraj Chowdhury declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-218.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Despite advances in mechanical circulatory support, cardiac transplant remains the definitive treatment intervention for patients with advanced heart failure and refractory symptoms who cannot be managed with optimal medical therapy. This activity reviews the pathophysiology, diagnosis, and treatment of cardiac allograft vasculopathy, and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the epidemiology of cardiac allograft vasculopathy.</p></list-item><list-item><p>Describe the pathophysiology of cardiac allograft vasculopathy.</p></list-item><list-item><p>Outline the management options available for cardiac allograft vasculopathy.</p></list-item><list-item><p>Review the interprofessional team strategies for improving care coordination and communication to advance cardiac allograft vasculopathy and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=218&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=218">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-218.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>There are 5.1 million patients with chronic heart failure in the United States, and heart failure is the leading cause of hospitalization among adults greater than 65 years of age.<xref ref-type="bibr" rid="article-218.r1">[1]</xref>&#x000a0;With more than 1 million patients being hospitalized for the primary diagnosis of heart failure, Medicare spending exceeds $17 billion per annum on this diagnosis.<xref ref-type="bibr" rid="article-218.r2">[2]</xref>&#x000a0;Despite advances in mechanical circulatory support, cardiac transplant remains the definitive treatment intervention for patients with advanced heart failure and refractory symptoms who cannot be managed with optimal medical therapy.</p>
        <p>Since the first human heart transplant by Dr. Christiaan Barnard in 1967, a slew of disruptive innovations and multidisciplinary efforts have sophisticated the field.<xref ref-type="bibr" rid="article-218.r3">[3]</xref>&#x000a0;At present, over 5,000 heart transplants are carried out worldwide every year.<xref ref-type="bibr" rid="article-218.r4">[4]</xref>&#x000a0;Despite the encouraging numbers, obstacles still exist.</p>
        <p>Cardiac allograft vasculopathy (CAV) is a recognized long-term complication seen post-cardiac transplant. Considered a chronic fibroproliferative rejection to the transplanted heart, it is amongst the top three causes of death after the first year of transplantation. The prevalence of CAV in patients post-cardiac transplant at 1, 5, and 10 years was 8%, 29%, and 47%, respectively as described by the 2019 International Society for Heart and Lung Transplantation (ISHLT) registry data report.<xref ref-type="bibr" rid="article-218.r5">[5]</xref></p>
      </sec>
      <sec id="article-218.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Cardiac allograft vasculopathy is a pan-arterial disease limited to the allograft. Its etiology is multifactorial in origin, with the primary cause being inflammation driven by both cellular and antibody-mediated rejection processes and anti-HLA antibodies against donor tissue. In accordance with the inflammatory burden in this disease process, elevation in serum C-reactive protein is a marker for CAV and allograft failure.<xref ref-type="bibr" rid="article-218.r6">[6]</xref><xref ref-type="bibr" rid="article-218.r7">[7]</xref><xref ref-type="bibr" rid="article-218.r8">[8]</xref>&#x000a0;Other contributing factors include hypercholesterolemia, diabetes, hypertension, and Cytomegalovirus infection.<xref ref-type="bibr" rid="article-218.r9">[9]</xref><xref ref-type="bibr" rid="article-218.r10">[10]</xref></p>
      </sec>
      <sec id="article-218.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Cardiac allograft vasculopathy is one of the top three causes of death 1-year post-cardiac transplant, accounting for an estimated 1 in 8 deaths in transplant survivors who live beyond one year.<xref ref-type="bibr" rid="article-218.r11">[11]</xref>&#x000a0;The prevalence of CAV in patients post-cardiac transplant at 1, 5, and 10 years was 8%, 29%, and 47%, respectively, as described by the 2019 International Society for Heart and Lung Transplantation (ISHLT) registry data report.<xref ref-type="bibr" rid="article-218.r5">[5]</xref>&#x000a0;Male donors and older age donors were linked to an increased risk of CAV.<xref ref-type="bibr" rid="article-218.r12">[12]</xref>&#x000a0;Younger aged recipients were found to be at a higher risk for CAV.<xref ref-type="bibr" rid="article-218.r13">[13]</xref><xref ref-type="bibr" rid="article-218.r14">[14]</xref></p>
      </sec>
      <sec id="article-218.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of CAV is complex, with an interplay of immunological and non-immunological factors. Inflammation may be triggered by donor arrest, organ procurement, and allograft ischemia and reperfusion. CAV is a pan-arterial process characterized by diffuse concentric hyperplasia of the intima seen in epicardial coronary arteries. It also extends to the microvasculature, causing concentric medial disease.<xref ref-type="bibr" rid="article-218.r15">[15]</xref><xref ref-type="bibr" rid="article-218.r16">[16]</xref><xref ref-type="bibr" rid="article-218.r17">[17]</xref>&#x000a0;This is in contrast to atherosclerosis, which is non-circumferential, focal, and common in the proximal epicardial vessels. Thrombotic occlusion of the vessel lumen, which is seen in atherosclerosis is an uncommon finding in CAV. However, the two frequently coexist. There is a strong association between platelet activation and CAV.<xref ref-type="bibr" rid="article-218.r18">[18]</xref>&#x000a0;This has been hypothesized as the reason for intramural thrombi formation associated with the disease.<xref ref-type="bibr" rid="article-218.r19">[19]</xref></p>
        <p>Intravascular ultrasound-guided studies have shown that most of the intimal thickening occurs during the first year post-transplant.<xref ref-type="bibr" rid="article-218.r20">[20]</xref>&#x000a0;An increase in maximal intimal thickness less than 0.5 mm within the first-year post-transplant is associated with an unfavorable prognosis.<xref ref-type="bibr" rid="article-218.r21">[21]</xref><xref ref-type="bibr" rid="article-218.r22">[22]</xref></p>
      </sec>
      <sec id="article-218.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Cardiac allograft vasculopathy encompasses a constellation of vascular changes characterized by intimal fibromuscular hyperplasia (arteriosclerosis), vasculitis, and atherosclerosis. Veins, in addition to arteries, are affected. Immunohistochemistry demonstrates the infiltration of macrophages and T lymphocytes into the intima, media, and/or adventitia of affected vessels. In contrast to atherosclerosis, calcium deposition is not a prominent finding, even in severely stenotic arteries.<xref ref-type="bibr" rid="article-218.r23">[23]</xref></p>
      </sec>
      <sec id="article-218.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Since the transplanted heart is denervated, the recipient typically does not perceive angina or ischemic pain. Thus, patients with CAV may be asymptomatic or complain of non-specific symptoms such as fatigue, dyspnea, palpitations, abdominal discomfort, and nausea.<xref ref-type="bibr" rid="article-218.r24">[24]</xref>&#x000a0;If the diagnosis is made late, after the onset of heart failure and reduced left ventricular ejection fraction, the prognosis is usually poor. In rare cases, sudden cardiac death may be the initial presentation of CAV. Consequently, surveillance testing is imperative to monitor recipients closely for early evidence of CAV as clinical manifestations are an unreliable metric.<xref ref-type="bibr" rid="article-218.r3">[3]</xref></p>
      </sec>
      <sec id="article-218.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>All post-cardiac transplant patients should undergo routine screening for&#x000a0;cardiac allograft vasculopathy, as early detection may improve prognosis.</p>
        <p>During the first 5 years post-transplant, coronary angiography should be performed every 1 or 2 years if renal function is preserved (estimated glomerular filtration rate &#x02265;30 to 40 mL/min/1.73 m). In cases of significant renal impairment (&#x0003c;30 to 40 mL/min/1.73 m), annual dobutamine stress echocardiography should be performed to assess for inducible coronary ischemia.<xref ref-type="bibr" rid="article-218.r25">[25]</xref><xref ref-type="bibr" rid="article-218.r26">[26]</xref>&#x000a0;Dobutamine stress echo has been extensively validated as a non-invasive assessment correlating with prognosis in post-cardiac transplant patients.<xref ref-type="bibr" rid="article-218.r27">[27]</xref><xref ref-type="bibr" rid="article-218.r28">[28]</xref><xref ref-type="bibr" rid="article-218.r29">[29]</xref>&#x000a0;</p>
        <p>Five years post-transplant, low-risk patients can continue surveillance with annual dobutamine stress echocardiography. If patients have evidence of evolving CAV, they should undergo annual coronary angiograms so long as renal function permits. For those patients with poor quality echocardiography images, a dobutamine or dipyridamole stress radionuclide myocardial perfusion study can be performed.<xref ref-type="bibr" rid="article-218.r30">[30]</xref></p>
        <p>Coronary angiography should be performed on post-transplant patients who present with a change in clinical status and graft dysfunction with a drop in left ventricular ejection fraction, which cannot be explained by acute rejection.</p>
        <p>It should be noted that CAV narrows the coronary arteries in a diffuse, concentric pattern, unlike atherosclerosis, which is eccentric and focal and easier to detect on coronary angiography. Thus, angiography has its limitations, especially in early CAV, and may underestimate the severity and burden of the disease. Intravascular ultrasound (IVUS), in conjunction with coronary flow reserve measurements, overcome this limitation.<xref ref-type="bibr" rid="article-218.r31">[31]</xref><xref ref-type="bibr" rid="article-218.r32">[32]</xref><xref ref-type="bibr" rid="article-218.r33">[33]</xref><xref ref-type="bibr" rid="article-218.r34">[34]</xref><xref ref-type="bibr" rid="article-218.r35">[35]</xref>&#x000a0;In the future, optical coherence tomography (OCT) may replace or supplement intravascular ultrasound (IVUS) as it allows for high-resolution assessment of the coronary artery wall architecture and composition.<xref ref-type="bibr" rid="article-218.r36">[36]</xref>&#x000a0;Conversely, the absence of coronary angiographic disease was a predictor of survival without adverse cardiac events at two years.<xref ref-type="bibr" rid="article-218.r37">[37]</xref></p>
        <p>Once the diagnosis of CAV has been established, echocardiograms should be performed to follow left ventricular ejection fraction and allograft dysfunction serially. In addition, annual coronary angiograms aid in the diagnosis of lesions amenable to percutaneous coronary interventions or, in advanced cases, if re-transplantation should be considered.</p>
      </sec>
      <sec id="article-218.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Prevention of Cardiac Allograft Vasculopathy</bold>
</p>
        <p><bold>mTOR inhibitors</bold> such as everolimus and sirolimus have been shown to prevent or slow the progression of cardiac allograft vasculopathy given their anti-proliferative properties. However, adverse effects, such as renal impairment and impaired wound healing, may limit their use.<xref ref-type="bibr" rid="article-218.r38">[38]</xref><xref ref-type="bibr" rid="article-218.r39">[39]</xref><xref ref-type="bibr" rid="article-218.r40">[40]</xref></p>
        <p><bold>Statin therapy</bold> has been shown to reduce the incidence of CAV post-transplant. In addition, these patients have a high incidence of hyperlipidemia, which is also benefitted by statin therapy.<xref ref-type="bibr" rid="article-218.r41">[41]</xref>&#x000a0;Thus, all post-transplant patients should be on statin therapy. Within the statin group, pravastatin and simvastatin have proven to improve survival in these patients.<xref ref-type="bibr" rid="article-218.r42">[42]</xref><xref ref-type="bibr" rid="article-218.r43">[43]</xref></p>
        <p>
<bold>Treatment of CAV</bold>
</p>
        <p>Short-term augmentation of immunosuppressive therapy with mTOR inhibitors may halt progression or cause regression of CAV;&#x000a0;however, more data are required to substantiate this.<xref ref-type="bibr" rid="article-218.r44">[44]</xref>&#x000a0;In addition, the risks of increased immunosuppression, including infection and malignancy, may negate these supposed benefits. In a cohort of 163 post-cardiac transplant patients, the anti-CD-20 antibody rituximab was studied as a treatment for CAV. However, IVUS guided imaging showed an increased progression of CAV in patients on Rituximab as compared to placebo.<xref ref-type="bibr" rid="article-218.r45">[45]</xref></p>
        <p>If the extent of CAV is limited, percutaneous transluminal angioplasty may be used as a palliative option to treat discrete lesions; however, restenosis is a complication. In such cases, there may be a role for directional coronary atherectomy.<xref ref-type="bibr" rid="article-218.r46">[46]</xref>&#x000a0;Coronary artery bypass grafting has been performed in a selected group of cases with good medium-term outcomes. However, there remained a risk of disease progression and future need for percutaneous or surgical intervention. At this time, re-transplantation is the only definitive treatment option for patients with a significant burden of CAV.<xref ref-type="bibr" rid="article-218.r47">[47]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-218.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Graft dysfunction may present as acute or chronic heart failure or arrhythmias. In such cases, it is important to distinguish cardiac allograft vasculopathy from rejection reaction (cellular or humoral) and non-specific graft dysfunction. Rejection reactions are diagnosed on endomyocardial biopsy. If CAV is suspected, coronary angiography should be performed if renal function permits. The diffuse luminal narrowing is suggestive of CAV. In contrast, focal eccentric lesions, more commonly in the proximal epicardial vessels is more suggestive of atherosclerosis, though the two may exist in tandem.</p>
        <list list-type="bullet">
          <list-item>
            <p>Atherosclerosis</p>
          </list-item>
          <list-item>
            <p>Non-specific graft dysfunction</p>
          </list-item>
          <list-item>
            <p>Posttransplantation lymphoproliferative disorder</p>
          </list-item>
          <list-item>
            <p>Transplant rejection</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-218.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The presence of cardiac allograft vasculopathy portends a worse prognosis for patients post-cardiac transplant. A reliable surrogate marker for subsequent mortality, non-fatal major adverse cardiac events, and development of angiographically significant CAV through five years post-transplant is the progression of intimal thickening &#x02265;0.5&#x000a0;mm in the first year post-transplant.<xref ref-type="bibr" rid="article-218.r21">[21]</xref>&#x000a0;The prevalence of CAV in patients post-cardiac transplant at 1, 5, and 10 years was 8%, 29%, and 47% respectively, as described by the 2019 International Society for Heart and Lung Transplantation (ISHLT) registry data report.<xref ref-type="bibr" rid="article-218.r5">[5]</xref><xref ref-type="bibr" rid="article-218.r48">[48]</xref></p>
      </sec>
      <sec id="article-218.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Cardiac allograft vasculopathy may manifest as graft dysfunction in the form of arrhythmias, acute or chronic heart failure and in the worst cases as sudden cardiac death.</p>
      </sec>
      <sec id="article-218.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Proper diagnosis and management of cardiac allograft vasculopathy can majorly impact a heart transplant patient's lifespan and can have long-term quality of life effects. Healthcare practitioners should thoroughly counsel patients post-cardiac transplant about the implications of cardiac allograft vasculopathy so that they can make informed decisions about their treatment.</p>
      </sec>
      <sec id="article-218.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of cardiac allograft vasculopathy in post-cardiac transplant patients requires an interprofessional team of healthcare professionals that includes a nurse, physician assistant, laboratory technologists, pharmacists, pathologists, social workers, and a number of physicians in different specialties. Before the transplant, a social worker must assess the patient's socioeconomic factors to see if compliance with medication and support through the process of transplant is adequate. Nurses, especially advanced practice nurses, and PAs play an essential link between patients and cardiologists. Given the&#x000a0;high number of medications prescribed post-transplant, with various interactions and side effects, pharmacists become an integral part of the management team, and emphasis should be placed on patient education. CAV may be confused for graft rejection, in which case endomyocardial biopsies aid in the diagnosis, and for this,&#x000a0;a&#x000a0;pathologist trained in immunology is vital. Lastly, not only cardiologists and cardiac surgeons but primary care physicians, nephrologists, hemato-oncologists, and pulmonologists may have a role to play in the management of these patients, and interprofessional rounds during inpatient hospitalizations are imperative to improving the quality of care delivered.</p>
      </sec>
      <sec id="article-218.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=218&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=218">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/heart-transplantation-allograft-vasculopathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=218">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/218/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=218">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-218.s16">
        <fig id="article-218.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Heart Transplantation Allograft Vasculopathy, heart transplantation, vasculopathy, coronary artery disease, intimal thickening, vessels, atherosclerosis, plaque Illustration by Emma Gregory</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Heart_Transplantation_Allograft_Vasculopathy-01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-218.s17">
        <title>References</title>
        <ref id="article-218.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>WRITING COMMITTEE MEMBERS</collab>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Geraci</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Horwich</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Januzzi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wilkoff</surname>
                <given-names>BL</given-names>
              </name>
              <collab>American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.</article-title>
            <source>Circulation</source>
            <year>2013</year>
            <month>Oct</month>
            <day>15</day>
            <volume>128</volume>
            <issue>16</issue>
            <fpage>e240</fpage>
            <page-range>e240-327</page-range>
            <pub-id pub-id-type="pmid">23741058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosamond</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Flegal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Furie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Go</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Greenlund</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Haase</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hailpern</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kissela</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kittner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meigs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nichol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sorlie</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Steinberger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thom</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>Y</given-names>
              </name>
              <collab>American Heart Association Statistics Committee and Stroke Statistics Subcommittee</collab>
            </person-group>
            <article-title>Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.</article-title>
            <source>Circulation</source>
            <year>2008</year>
            <month>Jan</month>
            <day>29</day>
            <volume>117</volume>
            <issue>4</issue>
            <fpage>e25</fpage>
            <page-range>e25-146</page-range>
            <pub-id pub-id-type="pmid">18086926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stehlik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Reichenspurner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kirklin</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Honoring 50 Years of Clinical Heart Transplantation in <italic>Circulation</italic>: In-Depth State-of-the-Art Review.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Jan</month>
            <day>02</day>
            <volume>137</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-87</page-range>
            <pub-id pub-id-type="pmid">29279339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lund</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Khush</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Cherikh</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kucheryavaya</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Levvey</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Meiser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rossano</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Chambers</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Yusen</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Stehlik</surname>
                <given-names>J</given-names>
              </name>
              <collab>International Society for Heart and Lung Transplantation</collab>
            </person-group>
            <article-title>The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>10</issue>
            <fpage>1037</fpage>
            <page-range>1037-1046</page-range>
            <pub-id pub-id-type="pmid">28779893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khush</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Cherikh</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Chambers</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Harhay</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hsich</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Meiser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Potena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rossano</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Sadavarte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Zuckermann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stehlik</surname>
                <given-names>J</given-names>
              </name>
              <collab>International Society for Heart and Lung Transplantation</collab>
            </person-group>
            <article-title>The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>10</issue>
            <fpage>1056</fpage>
            <page-range>1056-1066</page-range>
            <pub-id pub-id-type="pmid">31548031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisenberg</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Warshofsky</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Sciacca</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Wasserman</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rabbani</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients.</article-title>
            <source>Circulation</source>
            <year>2000</year>
            <month>Oct</month>
            <day>24</day>
            <volume>102</volume>
            <issue>17</issue>
            <fpage>2100</fpage>
            <page-range>2100-4</page-range>
            <pub-id pub-id-type="pmid">11044427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Labarrere</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Al-Hassani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Pitts</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study.</article-title>
            <source>Lancet</source>
            <year>2002</year>
            <month>Nov</month>
            <day>09</day>
            <volume>360</volume>
            <issue>9344</issue>
            <fpage>1462</fpage>
            <page-range>1462-7</page-range>
            <pub-id pub-id-type="pmid">12433514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hognestad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Endresen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wergeland</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stokke</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Geiran</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Holm</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Simonsen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kjekshus</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Andreassen</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2003</year>
            <month>Aug</month>
            <day>06</day>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>477</fpage>
            <page-range>477-82</page-range>
            <pub-id pub-id-type="pmid">12906976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Reyne</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>de Dios</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Medrano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jurado</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Juan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Ruiz-Cano</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dolores Folgueira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-S&#x000e1;nchez</surname>
                <given-names>M&#x000c1;</given-names>
              </name>
              <name>
                <surname>Aguado</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lumbreras</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>8</issue>
            <fpage>1112</fpage>
            <page-range>1112-9</page-range>
            <pub-id pub-id-type="pmid">25940077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Current diagnostic and treatment strategies for cardiac allograft vasculopathy.</article-title>
            <source>Expert Rev Cardiovasc Ther</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>10</issue>
            <fpage>1147</fpage>
            <page-range>1147-54</page-range>
            <pub-id pub-id-type="pmid">26401922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lund</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Kucheryavaya</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Benden</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dipchand</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Levvey</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Meiser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rossano</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Yusen</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Stehlik</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme: Early Graft Failure.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>10</issue>
            <fpage>1244</fpage>
            <page-range>1244-54</page-range>
            <pub-id pub-id-type="pmid">26454738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Alderman</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1997</year>
            <month>Mar</month>
            <day>01</day>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>623</fpage>
            <page-range>623-9</page-range>
            <pub-id pub-id-type="pmid">9060902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Transplant coronary disease: nonimmunologic risk factors.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>1992</year>
            <season>May-Jun</season>
            <volume>11</volume>
            <issue>3 Pt 2</issue>
            <fpage>S124</fpage>
            <page-range>S124-32</page-range>
            <pub-id pub-id-type="pmid">1622991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoica</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Cafferty</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pauriah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Sharples</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Wallwork</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Large</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Parameshwar</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The cumulative effect of acute rejection on development of cardiac allograft vasculopathy.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>420</fpage>
            <page-range>420-5</page-range>
            <pub-id pub-id-type="pmid">16563972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>De Franco</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Goormastic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Rincon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bott-Silverman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nissen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1996</year>
            <month>Mar</month>
            <day>15</day>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>839</fpage>
            <page-range>839-46</page-range>
            <pub-id pub-id-type="pmid">8613612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanaka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sukhova</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schoen</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Libby</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A.</article-title>
            <source>Transplant Proc</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>2062</fpage>
            <page-range>2062-5</page-range>
            <pub-id pub-id-type="pmid">7792886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hiemann</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Wellnhofer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Knosalla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lehmkuhl</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hetzer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies.</article-title>
            <source>Circulation</source>
            <year>2007</year>
            <month>Sep</month>
            <day>11</day>
            <volume>116</volume>
            <issue>11</issue>
            <fpage>1274</fpage>
            <page-range>1274-82</page-range>
            <pub-id pub-id-type="pmid">17709643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fateh-Moghadam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bocksch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ruf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dickfeld</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schartl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pog&#x000e1;tsa-Murray</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hetzer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fleck</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gawaz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy.</article-title>
            <source>Circulation</source>
            <year>2000</year>
            <month>Aug</month>
            <day>22</day>
            <volume>102</volume>
            <issue>8</issue>
            <fpage>890</fpage>
            <page-range>890-7</page-range>
            <pub-id pub-id-type="pmid">10952958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arbustini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dal Bello</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Morbini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gavazzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Specchia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vigan&#x000f2;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemical characterization of coronary thrombi in allograft vascular disease.</article-title>
            <source>Transplantation</source>
            <year>2000</year>
            <month>Mar</month>
            <day>27</day>
            <volume>69</volume>
            <issue>6</issue>
            <fpage>1095</fpage>
            <page-range>1095-101</page-range>
            <pub-id pub-id-type="pmid">10762213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsutsui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ziada</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Schoenhagen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Iyisoy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Magyar</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Crowe</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Klingensmith</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Vince</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Rincon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Yamagishi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nissen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study.</article-title>
            <source>Circulation</source>
            <year>2001</year>
            <month>Aug</month>
            <day>07</day>
            <volume>104</volume>
            <issue>6</issue>
            <fpage>653</fpage>
            <page-range>653-7</page-range>
            <pub-id pub-id-type="pmid">11489770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Tobis</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Valantine</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mehra</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Anzai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Oeser</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Abeywickrama</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cretin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2005</year>
            <month>May</month>
            <day>03</day>
            <volume>45</volume>
            <issue>9</issue>
            <fpage>1532</fpage>
            <page-range>1532-7</page-range>
            <pub-id pub-id-type="pmid">15862430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chih</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Mielniczuk</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Beanlands</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2016</year>
            <month>Jul</month>
            <day>05</day>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-91</page-range>
            <pub-id pub-id-type="pmid">27364054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Palatnik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Perens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alejos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>1044</fpage>
            <page-range>1044-50</page-range>
            <pub-id pub-id-type="pmid">21640617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Billingham</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Valantine</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Stinson</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Acute myocardial infarction in cardiac transplant recipients.</article-title>
            <source>Am J Cardiol</source>
            <year>1989</year>
            <month>Nov</month>
            <day>15</day>
            <volume>64</volume>
            <issue>18</issue>
            <fpage>1093</fpage>
            <page-range>1093-7</page-range>
            <pub-id pub-id-type="pmid">2816760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehra</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Crespo-Leiro</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Dipchand</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ensminger</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hiemann</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Madsen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Parameshwar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Uber</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>717</fpage>
            <page-range>717-27</page-range>
            <pub-id pub-id-type="pmid">20620917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Badano</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Miglioranza</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Edvardsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Colafranceschi</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Muraru</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bacal</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nieman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zoppellaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marcondes Braga</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <collab>Document reviewers</collab>
            </person-group>
            <article-title>European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.</article-title>
            <source>Eur Heart J Cardiovasc Imaging</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>919</fpage>
            <page-range>919-48</page-range>
            <pub-id pub-id-type="pmid">26139361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elhendy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Domburg</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Vantrimpont</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sozzi</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Bax</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Poldermans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roelandt</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Maat</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Balk</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Impact of heart transplantation on the safety and feasibility of the dobutamine stress test.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>399</fpage>
            <page-range>399-406</page-range>
            <pub-id pub-id-type="pmid">11295577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akosah</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>McDaniel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hanrahan</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mohanty</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Dobutamine stress echocardiography early after heart transplantation predicts development of allograft coronary artery disease and outcome.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>1607</fpage>
            <page-range>1607-14</page-range>
            <pub-id pub-id-type="pmid">9626841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spes</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Klauss</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mudra</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schnaack</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Tammen</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Rieber</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Siebert</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Henneke</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Uberfuhr</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reichart</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Theisen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Angermann</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound.</article-title>
            <source>Circulation</source>
            <year>1999</year>
            <month>Aug</month>
            <day>03</day>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>509</fpage>
            <page-range>509-15</page-range>
            <pub-id pub-id-type="pmid">10430765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Rocco</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jarcho</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ganz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mudge</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive assessment of transplant-associated arteriosclerosis.</article-title>
            <source>Am Heart J</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>135</volume>
            <issue>6 Pt 1</issue>
            <fpage>980</fpage>
            <page-range>980-7</page-range>
            <pub-id pub-id-type="pmid">9630101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Alderman</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Wiederhold</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stinson</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Progressive coronary luminal narrowing after cardiac transplantation.</article-title>
            <source>Circulation</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>82</volume>
            <issue>5 Suppl</issue>
            <fpage>IV269</fpage>
            <page-range>IV269-75</page-range>
            <pub-id pub-id-type="pmid">2225415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>St Goar</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Alderman</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Stinson</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Billingham</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Popp</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound.</article-title>
            <source>Circulation</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>756</fpage>
            <page-range>756-63</page-range>
            <pub-id pub-id-type="pmid">1516187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Sachar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ziada</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Crowe</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Magyar</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nissen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2005</year>
            <month>May</month>
            <day>03</day>
            <volume>45</volume>
            <issue>9</issue>
            <fpage>1538</fpage>
            <page-range>1538-42</page-range>
            <pub-id pub-id-type="pmid">15862431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehra</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ventura</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Stapleton</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Smart</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Ramee</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>1995</year>
            <season>Jul-Aug</season>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>632</fpage>
            <page-range>632-9</page-range>
            <pub-id pub-id-type="pmid">7578168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wellnhofer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stypmann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bara</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Stadlbauer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heidt</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kreider-Stempfle</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Zeh</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Comberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eckert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dengler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ensminger</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hiemann</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Angiographic assessment of cardiac allograft vasculopathy: results of a Consensus Conference of the Task Force for Thoracic Organ Transplantation of the German Cardiac Society.</article-title>
            <source>Transpl Int</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>11</issue>
            <fpage>1094</fpage>
            <page-range>1094-104</page-range>
            <pub-id pub-id-type="pmid">20477994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maehara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nazif</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Rabbani</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Apfelbaum</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Marboe</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Weisz</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography.</article-title>
            <source>Am J Cardiol</source>
            <year>2016</year>
            <month>Apr</month>
            <day>15</day>
            <volume>117</volume>
            <issue>8</issue>
            <fpage>1361</fpage>
            <page-range>1361-8</page-range>
            <pub-id pub-id-type="pmid">26920081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lazem</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Banner</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yacoub</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The prognostic significance of non-invasive cardiac tests in heart transplant recipients.</article-title>
            <source>Eur Heart J</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>692</fpage>
            <page-range>692-6</page-range>
            <pub-id pub-id-type="pmid">9129903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Dorent</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Valantine-von Kaeppler</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>S&#x000f8;rensen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hummel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lind</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Abeywickrama</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Bernhardt</surname>
                <given-names>P</given-names>
              </name>
              <collab>RAD B253 Study Group</collab>
            </person-group>
            <article-title>Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Aug</month>
            <day>28</day>
            <volume>349</volume>
            <issue>9</issue>
            <fpage>847</fpage>
            <page-range>847-58</page-range>
            <pub-id pub-id-type="pmid">12944570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Pauly</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Kfoury</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Cantin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Van Bakel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ewald</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hirt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lehmkuhl</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Keogh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Potena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zuckermann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cornu-Artis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.</article-title>
            <source>Am J Transplant</source>
            <year>2013</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>1203</fpage>
            <page-range>1203-16</page-range>
            <pub-id pub-id-type="pmid">23433101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keogh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ruygrok</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spratt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Galbraith</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Driscoll</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Esmore</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Faddy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Oct</month>
            <day>26</day>
            <volume>110</volume>
            <issue>17</issue>
            <fpage>2694</fpage>
            <page-range>2694-700</page-range>
            <pub-id pub-id-type="pmid">15262845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bilchick</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Henrikson</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Skojec</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Treatment of hyperlipidemia in cardiac transplant recipients.</article-title>
            <source>Am Heart J</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>148</volume>
            <issue>2</issue>
            <fpage>200</fpage>
            <page-range>200-10</page-range>
            <pub-id pub-id-type="pmid">15308989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Katznelson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Laks</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Yeatman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Chia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Terasaki</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Sabad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cogert</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Effect of pravastatin on outcomes after cardiac transplantation.</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <month>Sep</month>
            <day>07</day>
            <volume>333</volume>
            <issue>10</issue>
            <fpage>621</fpage>
            <page-range>621-7</page-range>
            <pub-id pub-id-type="pmid">7637722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meiser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thiery</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nagel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>von Scheidt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Steinbeck</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Seidel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reichart</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial.</article-title>
            <source>Circulation</source>
            <year>1997</year>
            <month>Sep</month>
            <day>02</day>
            <volume>96</volume>
            <issue>5</issue>
            <fpage>1398</fpage>
            <page-range>1398-402</page-range>
            <pub-id pub-id-type="pmid">9315523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamich</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ballester</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brossa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aymat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carri&#x000f3;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bern&#x000e0;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Campreci&#x000f3;s</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Puig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Estorch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Flotats</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bordes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aug&#x000e8;</surname>
              </name>
              <name>
                <surname>Padr&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Caralps</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>413</fpage>
            <page-range>413-9</page-range>
            <pub-id pub-id-type="pmid">9708469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bridges</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Eisen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Givertz</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kfoury</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Kobashigawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ikle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Pinney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stehlik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tripathi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sayegh</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Chandraker</surname>
                <given-names>A</given-names>
              </name>
              <collab>CTOT-11 Study Investigators</collab>
            </person-group>
            <article-title>Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Jul</month>
            <day>09</day>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-51</page-range>
            <pub-id pub-id-type="pmid">31272550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Ventura</surname>
                <given-names>HO</given-names>
              </name>
              <name>
                <surname>Ramee</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Isner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Directional coronary atherectomy in heart transplant recipients.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>1993</year>
            <season>Sep-Oct</season>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>819</fpage>
            <page-range>819-23</page-range>
            <pub-id pub-id-type="pmid">8241222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhama</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>DQ</given-names>
              </name>
              <name>
                <surname>Scolieri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Teuteberg</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Toyoda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kormos</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>McCurry</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bermudez</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Surgical revascularization for cardiac allograft vasculopathy: Is it still an option?</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>137</volume>
            <issue>6</issue>
            <fpage>1488</fpage>
            <page-range>1488-92</page-range>
            <pub-id pub-id-type="pmid">19464469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-218.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Tadwalkar</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Fearon</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Kirtane</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Cardiac allograft vasculopathy: A review.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2018</year>
            <month>Dec</month>
            <day>01</day>
            <volume>92</volume>
            <issue>7</issue>
            <fpage>E527</fpage>
            <page-range>E527-E536</page-range>
            <pub-id pub-id-type="pmid">30265435</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
